Atlas Trials

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

Clinical trial NCT03650361 · COMPLETED

Trial details

NCT number
NCT03650361
Sponsor
Aleor Dermaceuticals Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2018-09-17
Primary completion
2019-02-16
Enrollment
755

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.